Hyperpolarized Pyruvate (13C) Injection

DRUG3 trials

Sponsors

University of California, San Francisco, Sunnybrook Health Sciences Centre

Conditions

Breast CancerProstate CancerProstatic Neoplasms

Phase 1

Hyperpolarized Pyruvate Injection in Subjects With Prostate Cancer

CompletedNCT01229618

University of California, San FranciscoProstate Cancer

Start: 2010-10-31End: 2013-08-31Updated: 2015-10-05

Multiparametric MRI for Prostate Cancer Localization and Characterization Using Hyperpolarized Pyruvate (13C) Injection

WithdrawnNCT02647983

Sunnybrook Health Sciences CentreProstatic Neoplasms

Start: 2016-04-30End: 2019-10-31Updated: 2020-01-22

Study to Evaluate the Feasibility of 13-C Pyruvate Imaging in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy

WithdrawnNCT03121989

Sunnybrook Health Sciences CentreBreast Cancer

Start: 2017-11-21End: 2023-03-23Updated: 2023-03-30